ELND002

DRUG2 trials

Sponsors

Elan Pharmaceuticals

Conditions

Multiple Sclerosis

Phase 1

A Safety and Efficacy Study of ELND002 in Patients With Relapsing Forms of Multiple Sclerosis

TerminatedNCT01144351

Elan PharmaceuticalsMultiple Sclerosis

Start: 2010-03-31Updated: 2015-12-14

A Study of ELND002 in Patients With Relapsing Forms of Multiple Sclerosis

TerminatedNCT01318421

Elan PharmaceuticalsMultiple Sclerosis

Start: 2010-12-31Updated: 2015-12-14